Back to results
US 10,851,421 B2Granted
Next generation RNA-sequencing and long non-coding RNA in glioblastoma multiforme
AssigneeUniversity of Southern California
InventorsRose Lai, Chao Ling, Darryl Nousome, Kai Wang
Life of this patent
Estimating the term…
Abstract
LncRNAs are emerging as important oncogenic drivers in many cancers, but comprehensive, agnostic studies to identify key lncRNAs involved in GBM are lacking. Described herein are new lncRNA involved in gliomagenesis and prognosis, elucidating the biological functions of these relatively unknown biological actors and opening new therapeutic avenues for therapeutic development.
Claims10
A method of prognosing susceptibility to a brain tumor comprising:
- providing a sample from a subject;
- and
- detecting one or more long non-coding RNAs (lncRNAs) in the sample, wherein the detected level of the one or more lncRNAs in the same from the subject compared to a reference level of the one or more lncRNAs prognoses susceptibility to a brain tumor, wherein detecting one or more long non-coding RNAs (lncRNAs) comprises ribo-depleted RNA sequencing.
A method of determining the presence or absence of a brain tumor comprising:
- providing a sample from a subject;
- and
- detecting one or more long non-coding RNAs (lncRNAs) in the sample, wherein the detected level of the one or more lncRNAs in the same from the subject compared to a reference level of the one or more lncRNAs determines the presence or absence of a brain tumor in the subject, wherein detecting one or more long non-coding RNAs (lncRNAs) comprises ribo-depleted RNA sequencing.
Dependencies are inferred from the claim text.